UDOW240816P73000
- 0.50
- -0.20-28.57%
ProShares UltraPro Dow30 ETF Newsroom
BNP Paribas Exane Adjusts Price Target on Microsoft to $525 From $495, Maintains Outperform Rating
Buy Rating on UnitedHealth Group: Proactive Management and Strong Growth Outlook
BNP Paribas Exane Adjusts Price Target on Goldman Sachs to $485 From $415, Maintains Neutral Rating
Deutsche Bank Raises Price Target on UnitedHealth Group to $632 From $562, Keeps Buy Rating
UnitedHealth Group Analyst Ratings
UBS Adjusts UnitedHealth Group Price Target to $680 From $640, Maintains Buy Rating
Elevance Extends Losses as BofA Cuts on Medicaid Headwinds
Microsoft Analyst Ratings
TD Cowen Adjusts Price Target on Microsoft to $495 From $470, Maintains Buy Rating
Barclays Keeps Their Hold Rating on Caterpillar (CAT)
UnitedHealth's Strong Q2 Performance and Strategic Initiatives Secure Buy Rating
UnitedHealth (UNH) Gets a Buy From Cantor Fitzgerald
Jefferies Upgrades UnitedHealth to Buy, Cites Growth Outlook
Barclays Keeps Their Buy Rating on UnitedHealth (UNH)
Analysts Conflicted on These Healthcare Names: UnitedHealth (UNH) and Biogen (BIIB)
UnitedHealth Group Maintains Buy Rating: Sustainable Growth and Strategic Positioning Fuel Long-Term Trajectory
Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH), Veeva Systems (VEEV) and Arrowhead Pharmaceuticals (ARWR)
BMO Capital Maintains Market Perform on Goldman Sachs Gr, Raises Price Target to $373
UnitedHealth Group Analyst Ratings
RBC Raises Price Target on UnitedHealth Group to $615 From $555, Keeps Outperform Rating